About Us

Progenra, Inc. pursuing novel Molecular Glue and PROTAC approaches by exploiting the ubiquitin proteasome system for drug discovery in different therapeutic areas. Its UbiPro™ Drug Discovery Platform is a multi-faceted approach based on the physiological milieux in which enzymes of the ubiquitin proteasome system interact with their substrates. This approach has led to breakthroughs in developing drug candidates for evaluation and progression in the clinic.

Our Mission

Progenra’s mission is to leverage its expertise in the ubiquitin proteasome system, Molecular Glues and PROTAC drugs, to discover and develop novel, first in class medicines to fill unmet needs in a spectrum of therapeutic areas.